MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $965,178 | -18.1% | 6,609 | +29.6% | 0.00% | 0.0% |
Q2 2023 | $1,178,100 | -87.9% | 5,100 | -87.3% | 0.00% | -85.7% |
Q1 2023 | $9,710,750 | -66.8% | 40,084 | -60.2% | 0.02% | -53.3% |
Q4 2022 | $29,228,175 | +281.6% | 100,700 | +64.7% | 0.04% | +400.0% |
Q1 2019 | $7,660,000 | +7.6% | 61,149 | -3.2% | 0.01% | 0.0% |
Q4 2018 | $7,120,000 | -45.5% | 63,169 | +3.6% | 0.01% | -43.8% |
Q3 2018 | $13,062,000 | +22420.7% | 61,000 | +9582.5% | 0.02% | – |
Q4 2017 | $58,000 | – | 630 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |